Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Poly binding protein cytoplasmic 1 pseudogene 3 (PABPC1P3) is a pseudogene related to the poly(A) binding protein family, specifically PABPC1, which encodes a protein involved in binding to the poly(A) tail of mRNAs and regulating their stability, export, translation, and degradation in the cytoplasm[1][3][4]. PABPC1P3 is a non-functional copy, does not produce protein, and is not considered a molecular target in therapeutic contexts. It is important to distinguish PABPC1P3 (pseudogene) from PABPC1 (protein-coding gene), as only the latter has defined biological roles and relevance as a molecular target.
None.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Poly binding protein cytoplasmic 1 pseudogene 3 (PABPC1P3).